Kyphon Gains X Stop Spinal Stenosis Treatment Via $725 Mil. St. Francis Deal

Kyphon will use its established spinal sales force to drive market adoption of St. Francis Medical's X Stop minimally invasive spinal stenosis treatment after acquiring the company in a deal worth up to $725 mil

More from Archive

More from Medtech Insight